Xiaoling Su

903 citations
42 papers · 642 · h-index 17

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • Metabolomics and Mass Spectrometry Studies
    • Gut microbiota and health
    • Glycosylation and Glycoproteins Research

Papers in

    • Metabolomics and Mass Spectrometry Studies 9
    • Gut microbiota and health 6
    • vaccines and immunoinformatics approaches 3
    • RNA modifications and cancer 3
    • Liver Disease Diagnosis and Treatment 5

Xiaoling Su

38 papers receiving 637 citations

Peers

Xiaoling Su
Comparison fields: 5 of 88
  • Infectious Diseases 90
  • Molecular Biology 347
  • Microbiology 29
  • Spectroscopy 77
  • Cancer Research 43
Replace Karin Zemski Berry with:
Karin Zemski Berry United States
Cui Li China
Shelley A. Deeke Canada
Ruth Singleton Canada
Erica S. Lovelace United States
Tongyi Shen China
Alison R. Erickson United States
Deb N. Chakravarti United States
Nicholas J. Bond United Kingdom
Edna A. Trujillo United States
Xiaoling Su relative to Karin Zemski Berry United States Karin Zemski Berry's profile →
Citations per field
00.5×3.1×
Karin Zemski Berry · 1×
Citations per year

Countries citing papers authored by Xiaoling Su

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Su more than expected).

Fields of papers citing papers by Xiaoling Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Su. The network helps show where Xiaoling Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling Su Line = papers co-authored together Xiaoling Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201469
2 201564
3 202144
4 202240
5 202134
6 201030
7 201730
8 201529
9 202226
10 201625
11 202223
12 201722
13 202221
14 201921
15 202420
16 202219
17 202316
18 202116
19 202416
20 202314

About Xiaoling Su

Xiaoling Su is a scholar working on Molecular Biology, Epidemiology, Immunology, Infectious Diseases and Physiology, having authored 42 papers that have together received 642 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (9 papers), Gut microbiota and health (6 papers), Liver Disease Diagnosis and Treatment (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Diet and metabolism studies (5 papers), Microbial infections and disease research (3 papers), vaccines and immunoinformatics approaches (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Infectious Diseases (90 citations), Molecular Biology (347 citations), Microbiology (29 citations), Spectroscopy (77 citations) and Cancer Research (43 citations). Xiaoling Su has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Deying Chen, Lanjuan Li, Liang Li, Zeyu Sun, Nan Wang, Yingfeng Lu, Wei Xu, Tao Huan, Jing Jiang and Chong Shen. Their work appears in journals such as Frontiers in Microbiology, Analytical Chemistry, Analytica Chimica Acta, Scientific Reports and Virulence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact